Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Zielinski

Showing results (21-30 of 546) with videos related to

Pageof 55
Sort By:
Der Radiologe|September 3, 1999
[Diagnostic imaging in clinical tumor staging]T Brodowicz, C C Zielinski
Cancer Treatment Reviews|February 24, 2009
Novel agents for renal cell carcinoma require novel selection paradigms to optimise first-line therapyManuela Schmidinger, Christoph C Zielinski
The New England Journal of Medicine|June 30, 2000
Warfarin for cancer preventionC C Zielinski, M Hejna
Annals of Thoracic Medicine|November 10, 2017
Saudi lung cancer management guidelines 2017: Improving lung cancer care in Saudi regionChristian Rolfo, Christoph C Zielinski
Acta Medica Austriaca|January 1, 1988
[Chemotherapy of malignant adrenal gland tumors]C C Zielinski, G Schernthaner
Acta Medica Austriaca|January 1, 1987
[Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis]C Müller, C C Zielinski
Journal of Cancer Research and Clinical Oncology|May 11, 2010
Defining risk status in the first-line treatment of metastatic renal cell carcinomaManuela Schmidinger, Christoph C Zielinski
Expert Review of Anticancer Therapy|July 13, 2002
Nonsurgical management of gallbladder cancer: cytotoxic treatment and radiotherapyM Hejna, C C Zielinski
ESMO Open|November 16, 2016
AIOM chooses <i>ESMO Open-Cancer Horizons</i> as its official journal: a warm welcome from <i>ESMO Open</i>Christoph C Zielinski, Carmine Pinto
Journal of Hepatology|July 1, 1992
Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitisC Müller, C C Zielinski
Pageof 55

Showing results (21-30 of 546) with videos related to

Sort By:
Pageof 55
Der Radiologe|September 3, 1999
[Diagnostic imaging in clinical tumor staging]T Brodowicz, C C Zielinski
Cancer Treatment Reviews|February 24, 2009
Novel agents for renal cell carcinoma require novel selection paradigms to optimise first-line therapyManuela Schmidinger, Christoph C Zielinski
The New England Journal of Medicine|June 30, 2000
Warfarin for cancer preventionC C Zielinski, M Hejna
Annals of Thoracic Medicine|November 10, 2017
Saudi lung cancer management guidelines 2017: Improving lung cancer care in Saudi regionChristian Rolfo, Christoph C Zielinski
Acta Medica Austriaca|January 1, 1988
[Chemotherapy of malignant adrenal gland tumors]C C Zielinski, G Schernthaner
Acta Medica Austriaca|January 1, 1987
[Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis]C Müller, C C Zielinski
Journal of Cancer Research and Clinical Oncology|May 11, 2010
Defining risk status in the first-line treatment of metastatic renal cell carcinomaManuela Schmidinger, Christoph C Zielinski
Expert Review of Anticancer Therapy|July 13, 2002
Nonsurgical management of gallbladder cancer: cytotoxic treatment and radiotherapyM Hejna, C C Zielinski
ESMO Open|November 16, 2016
AIOM chooses <i>ESMO Open-Cancer Horizons</i> as its official journal: a warm welcome from <i>ESMO Open</i>Christoph C Zielinski, Carmine Pinto
Journal of Hepatology|July 1, 1992
Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitisC Müller, C C Zielinski
Pageof 55